Compare Stocks → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:CDSGNASDAQ:DTEAOTCMKTS:NUGNNASDAQ:YTEN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDSGChina Dongsheng International$0.01-11.1%$0.01$0.01▼$0.19$2.06M14.94644,199 shs1.20 million shsDTEADAVIDsTEA$0.28$0.31$0.42▼$2.70$7.52M2.6643,487 shs76 shsNUGNLivento Group$0.01$0.01$0.00▼$0.07$8.00M4.81514,180 shs196,339 shsYTENYield10 Bioscience$0.23-11.5%$0.29$0.18▼$3.29$3.54M1.584.05 million shs1.10 million shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDSGChina Dongsheng International-11.11%-5.88%+12.68%-55.56%-93.39%DTEADAVIDsTEA0.00%-8.15%-7.28%-27.46%-39.81%NUGNLivento Group-1.01%-2.00%-7.55%-2.00%-83.10%YTENYield10 Bioscience-10.47%-17.38%-36.08%+19.22%-91.95%The only accurate crypto trading system I know … (Ad)Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDSGChina Dongsheng InternationalN/AN/AN/AN/AN/AN/AN/AN/ADTEADAVIDsTEAN/AN/AN/AN/AN/AN/AN/AN/ANUGNLivento GroupN/AN/AN/AN/AN/AN/AN/AN/AYTENYield10 Bioscience0.5431 of 5 stars3.22.00.00.01.10.00.0Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDSGChina Dongsheng InternationalN/AN/AN/AN/ADTEADAVIDsTEAN/AN/AN/AN/ANUGNLivento GroupN/AN/AN/AN/AYTENYield10 Bioscience2.33Hold$3.501,421.08% UpsideCurrent Analyst RatingsLatest CDSG, YTEN, NUGN, and DTEA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/8/2024YTENYield10 BioscienceLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDSGChina Dongsheng InternationalN/AN/AN/AN/AN/AN/ADTEADAVIDsTEA$91.55M0.08$0.05 per share6.13$1.46 per share0.19NUGNLivento Group$2.01M3.98N/AN/A$0.10 per share0.10YTENYield10 Bioscience$60K59.06N/AN/A($0.21) per share-1.10Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDSGChina Dongsheng International-$100KN/A0.00∞N/AN/AN/AN/AN/ADTEADAVIDsTEA$62.38M-$0.30N/A∞N/A-10.92%-13.69%-8.24%N/ANUGNLivento Group-$6.55MN/A0.00∞N/A-326.32%-17.63%-16.02%N/AYTENYield10 Bioscience-$14.45M-$2.08N/A∞N/AN/A-888.81%-273.34%5/8/2024 (Estimated)Latest CDSG, YTEN, NUGN, and DTEA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/26/2024N/AYTENYield10 BioscienceN/A-$0.11-$0.11N/AN/AN/A4/1/2024Q4 2023YTENYield10 BioscienceN/A-$0.27-$0.27-$0.27N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDSGChina Dongsheng InternationalN/AN/AN/AN/AN/ADTEADAVIDsTEAN/AN/AN/AN/AN/ANUGNLivento GroupN/AN/AN/AN/AN/AYTENYield10 BioscienceN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDSGChina Dongsheng InternationalN/A0.050.05DTEADAVIDsTEAN/A2.501.17NUGNLivento GroupN/A2.602.60YTENYield10 BioscienceN/A0.290.29OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDSGChina Dongsheng InternationalN/ADTEADAVIDsTEA0.93%NUGNLivento Group0.36%YTENYield10 Bioscience4.91%Insider OwnershipCompanyInsider OwnershipCDSGChina Dongsheng International73.50%DTEADAVIDsTEA3.41%NUGNLivento GroupN/AYTENYield10 Bioscience6.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCDSGChina Dongsheng International8257.46 million68.23 millionNot OptionableDTEADAVIDsTEA25226.57 million25.67 millionNo DataNUGNLivento Group11815.90 millionN/ANot OptionableYTENYield10 Bioscience2915.40 million14.46 millionNot OptionableCDSG, YTEN, NUGN, and DTEA HeadlinesSourceHeadlineYield10 Bioscience (NASDAQ:YTEN) Stock Price Passes Above 200 Day Moving Average of $0.27americanbankingnews.com - April 19 at 3:20 AMYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 5 at 12:37 PMHold Recommendation on Yield10 Bioscience Amid Commercialization and Capital Uncertaintiesmarkets.businessinsider.com - April 3 at 6:59 PMQ4 2023 Yield10 Bioscience Inc Earnings Callfinance.yahoo.com - April 2 at 7:55 AMYTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023investorplace.com - April 1 at 9:06 PMYield10 Bioscience: Q4 Earnings Insightsbenzinga.com - April 1 at 4:54 PMYield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - April 1 at 4:01 PMYield10 Bioscience gets grant for genetically engineered oilseed plant expressing plant proteinpharmaceutical-technology.com - March 29 at 9:58 AMYield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024globenewswire.com - March 28 at 4:01 PMYield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canadaglobenewswire.com - March 26 at 8:29 AMUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesstockhouse.com - March 23 at 5:41 PMDow Jumps 200 Points; US Weekly Jobless Claims Fallmarkets.businessinsider.com - March 21 at 3:32 PMUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesmarkets.businessinsider.com - March 21 at 3:32 PMYield10 stock soars 120% on USDA okay for Camelina plantingmsn.com - March 21 at 3:32 PMUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesfinance.yahoo.com - March 21 at 3:32 PMWhy Is Yield10 (YTEN) Stock Up 117% Today?investorplace.com - March 21 at 11:05 AMUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesglobenewswire.com - March 21 at 8:29 AMYield10 Bioscience Inc.barrons.com - March 10 at 7:10 AMYield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Testsglobenewswire.com - February 29 at 8:31 AMYield10 Bioscience: Other Events, Financial Statements And Exhibitscbonds.com - February 16 at 10:00 AMYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstockfinance.yahoo.com - February 14 at 1:02 PMYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstockglobenewswire.com - February 14 at 9:00 AMYield10 Bioscience Accelerates Omega-3 Camelina Launchmsn.com - February 9 at 1:13 PMYield10 Bioscience, Inc.: Yield10 Bioscience Provides an Update on its Omega-3 Camelina Programfinanznachrichten.de - February 9 at 1:55 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsChina Dongsheng InternationalOTCMKTS:CDSGChina Dongsheng International, Inc. engages in the acquisition, exploration, and development of mineral properties. The company primarily explores for lithium. It holds an 80% interest in the Titan Projects located in Tanzania; and has right to earn 60% interest in the West End Lithium Project near Tonopah Nevada. China Dongsheng International, Inc. is based in Las Vegas, Nevada.DAVIDsTEANASDAQ:DTEADAVIDsTEA, Inc. operates as a beverage company. It offers a selection of loose-leaf teas, pre packaged teas, tea sachets, and tea-related gifts, food, and accessories through its stores. The firm operates through the Canada and U.S. segments. The company was founded by Herschel H. Segal and David Segal on April 29, 2008 and is headquartered in Mount-Royal, Canada.Livento GroupOTCMKTS:NUGNLivento Group, Inc. engages in the film and television production business. It is involved in the artificial intelligence and machine learning technology business; and real estate finance and development activities. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is headquartered in New York, New York.Yield10 BioscienceNASDAQ:YTENYield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.